In this week’s episode, Kenneth Kennedy discusses several of FDA’s strategies for helping stakeholders in the drug and medical device industry support health care providers in their fight against the COVID-19 outbreak. In particular, Mr. Kennedy discusses several unprecedented measures FDA has taken with respect to laboratory test approval, as well as some important regulatory actions aimed at protecting the public health.
Podden och tillhörande omslagsbild på den här sidan tillhör K&L Gates. Innehållet i podden är skapat av K&L Gates och inte av, eller tillsammans med, Poddtoppen.
